#Longcovid is a multifaceted disease; it can affect multiple organ systems including respiratory, cardiovascular, nervous, mental health, metabolic, gastrointestinal, kidneys, and other organ systems.
People with #longcovid have increased risk of incident use of several therapeutics including pain medications (opioids and non-opioids), antidepressants, anxiolytics, antihypertensives, and oral antihyperglycemics and evidence of laboratory abnormalities in multiple organ systems
#Longcovid is evident even in those who had mild acute disease which did not require hospitalization during the acute phase of the infection
Burden of #longCOVID increases substantially in those who required hospitalization, and is most pronounced in those who needed ICU care during the acute phase of the infection
When comparing the post-acute sequelea of COVID vs flu, COVID exhibited remarkably higher burden of post-acute sequalae. Both the magnitude of risk AND extent of organ system involvement were much higher than post-acute flu manifestations.
People with #longcovid need multidisciplinary care.
If there ever was an exemplar in clinical medicine that best illustrates the importance of integrated multidisciplinary care, it is #longcovid. Health systems should quickly adapt to this reality.
I can’t believe that I have to say this, but yes, #longcovid is real. People with long covid should be listened to, and their experiences must be honored.
Our new study in @naturemedicine comprehensively maps all the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound).
We saw that GLP1 use has substantially increased, and reports emerged about some off-target effects. But we realized that no one had comprehensively investigated effectiveness & risks of GLP-1 across all possible health outcomes nature.com/articles/s4159…
3. So, we decided to do the comprehensive study!
We did a discovery analysis which comprehensively examined 175 possible health outcomes (leaving no stone unturned) in 215,970 people on GLP1 and more than 2 million individuals not on GLP1
🚨 Long COVID is a significant health crisis in China too!
My commentary on the largest Chinese study to date, involving 74,075 participants, which found that 10-30% of them reported long COVID symptoms such as fatigue and brain fog #LongCovid
People who were randomly assigned to molnupiravir during the acute phase of COVID-19 had better outcomes at 3 months and 6 months than those randomly assigned to usual care
We review the mechanisms of Long Covid including viral persistence, immune dysfunction, thrombo-inflammation, neuronal inflammation, and microbiome dysbiosis. nature.com/articles/s4159…
We review the devastating impacts of Long Covid on individuals and communities, health systems, economies, and global health metrics.